Lunai Bioworks, Inc. Issues Letter to Shareholders
Lunai Bioworks, Inc. Issues Letter to Shareholders Lunai Bioworks, Inc. Issues Letter to Shareholders PR Newswire SACRAMENTO, Calif., Feb. 9, 2026 SACRAMENTO, Calif., Feb. 9, 2026 /PRNewswire...
PR Newswire·2d ago
More News
BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View
Biogen tops Q4 earnings and sales estimates, and shares rise after the company issues an encouraging 2026 adjusted EPS outlook despite revenue pressure.
Zacks·5d ago
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Receives Consensus Rating of "Hold" from Analysts
Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Get Free Report) have been assigned an average recommendation of "Hold" from the seven research firms that are covering the company, Marketbeat...
MarketBeat·6d ago
New Drugs Take Center Stage as Biogen Heads Into Q4 Earnings
Biogen heads into Q4 earnings with MS drug pressure, while Leqembi and Skyclarys' growth could help offset declines ahead of its Feb. 6 report.
Zacks·8d ago
Supernus Pharmaceuticals (NASDAQ:SUPN) Cut to "Strong Sell" at Zacks Research
Zacks Research downgraded shares of Supernus Pharmaceuticals from a "hold" rating to a "strong sell" rating in a research note on Thursday...
MarketBeat·11d ago
Great Lakes Advisors LLC Has $3.40 Million Holdings in Supernus Pharmaceuticals, Inc. $SUPN
Great Lakes Advisors LLC reduced its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 49.9% during the third quarter, according to the company in its most recent 13F filing...
MarketBeat·11d ago
Supernus Pharmaceuticals (NASDAQ:SUPN) Cut to "Buy" at Wall Street Zen
Wall Street Zen downgraded Supernus Pharmaceuticals from a "strong-buy" rating to a "buy" rating in a report on Saturday...
MarketBeat·11d ago
Ruffer LLP Makes New $2.65 Million Investment in Supernus Pharmaceuticals, Inc. $SUPN
Ruffer LLP purchased a new stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm...
MarketBeat·13d ago
Supernus Pharmaceuticals, Inc. $SUPN Shares Bought by Teacher Retirement System of Texas
Teacher Retirement System of Texas grew its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 648.9% in the third quarter, according to its most recent Form 13F filing with...
MarketBeat·15d ago
Supernus Pharmaceuticals, Inc. $SUPN Shares Bought by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 28.4% in the third quarter, according to the company in its...